Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Icendia understands that cancer cells generate a hostile microenvironment that prioritizes their survival while harming host tissues. To combat this, Incendia focuses on targeting the structural and biochemical foundations of the tumor microenvironment. This strategy aims to facilitate the access of host immune cells and immuno-oncology therapies, enhancing their ability to effectively target and destroy cancer cells. Through ...
Icendia understands that cancer cells generate a hostile microenvironment that prioritizes their survival while harming host tissues. To combat this, Incendia focuses on targeting the structural and biochemical foundations of the tumor microenvironment. This strategy aims to facilitate the access of host immune cells and immuno-oncology therapies, enhancing their ability to effectively target and destroy cancer cells. Through this innovative approach, we strive to improve treatment outcomes and empower the body’s immune system in the fight against cancer.

List your booth number for exhibitions, ask us